Last update 20 Mar 2025

Radspherin

Overview

Basic Info

Drug Type
Small molecule drug, Therapeutic radiopharmaceuticals
Synonyms
Ra-224 based therapeutic(Oncoinvent), Radium-224 based therapeutic(Oncoinvent)
+ [1]
Target-
Action-
Mechanism
Ionising radiation emitters
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
RegulationFast Track (United States)
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Endometrioid intraepithelial neoplasiaPhase 2
United States
15 Jun 2024
Endometrioid intraepithelial neoplasiaPhase 2
United Kingdom
15 Jun 2024
Endometrioid intraepithelial neoplasiaPhase 2
Belgium
15 Jun 2024
Endometrioid intraepithelial neoplasiaPhase 2
Spain
15 Jun 2024
Endometrioid intraepithelial neoplasiaPhase 2
Norway
15 Jun 2024
Primary peritoneal carcinomaPhase 2
Norway
15 Jun 2024
Primary peritoneal carcinomaPhase 2
United Kingdom
15 Jun 2024
Colorectal CancerPhase 2
Sweden
27 May 2020
Colorectal CancerPhase 2
Norway
27 May 2020
Peritoneal NeoplasmsPhase 2
Sweden
27 May 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
23
(fpfgbaqdxu) = mjzlxwuikj zjuhkbfsto (pugjnyazwn )
Positive
31 May 2023
Phase 1
23
(umdfyugjzw) = wnobteiusn fhbgqwacyt (bfddbtzatx )
Positive
02 Jun 2022
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free